Baranowski Lyn
Reporting owner on Forms 3, 4 and 5, CIK 1893640.
Baranowski Lyn reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-19.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| AVLN · Avalyn Pharma Inc.CIK 1540171 | director, officer (Chief Executive Officer) | 1 | 2026-11-19 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| AVLN · Avalyn Pharma Inc.Common Stock | 2026-11-18 | M exercised | +7,200 | $4.62 | 7,200 | Form 4 |
| AVLN · Avalyn Pharma Inc.Common Stock | 2026-11-18 | S sold | -6,465 | $27.9049 | 735 | Form 4 |
| AVLN · Avalyn Pharma Inc.Common Stock | 2026-11-18 | S sold | -735 | $28.3643 | 0 | Form 4 |
| AVLN · Avalyn Pharma Inc.Stock Option (Right to Buy), derivative | 2026-11-18 | M exercised | -7,200 | $0 | 610,833 | Form 4 |
| AVLN · Avalyn Pharma Inc.Common Stock | 2026-11-17 | M exercised | +45,300 | $4.62 | 45,300 | Form 4 |
| AVLN · Avalyn Pharma Inc.Common Stock | 2026-11-17 | S sold | -39,600 | $27.7604 | 5,700 | Form 4 |
| AVLN · Avalyn Pharma Inc.Common Stock | 2026-11-17 | S sold | -5,300 | $28.1514 | 400 | Form 4 |
| AVLN · Avalyn Pharma Inc.Common Stock | 2026-11-17 | S sold | -400 | $29.2249 | 0 | Form 4 |
| AVLN · Avalyn Pharma Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | M exercised | -45,300 | $0 | 618,033 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-468543 | Avalyn Pharma Inc. | 2026-11-19 |